IN2015DN02376A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02376A
IN2015DN02376A IN2376DEN2015A IN2015DN02376A IN 2015DN02376 A IN2015DN02376 A IN 2015DN02376A IN 2376DEN2015 A IN2376DEN2015 A IN 2376DEN2015A IN 2015DN02376 A IN2015DN02376 A IN 2015DN02376A
Authority
IN
India
Prior art keywords
crystal
luliconazole
plane
solubility
improving
Prior art date
Application number
Other languages
English (en)
Inventor
Takaaki; Masuda
Nohyaku Co Ltd Nihon
Original Assignee
Pola Pharma Inc
Nohyaku Co Ltd Nihon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nohyaku Co Ltd Nihon filed Critical Pola Pharma Inc
Publication of IN2015DN02376A publication Critical patent/IN2015DN02376A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN2376DEN2015 2012-09-14 2012-11-02 IN2015DN02376A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012202516 2012-09-14
PCT/JP2012/079050 WO2014041708A1 (en) 2012-09-14 2012-11-02 Crystal having crystal habits and pharmaceutical composition obtained by processing the crystal

Publications (1)

Publication Number Publication Date
IN2015DN02376A true IN2015DN02376A (enrdf_load_stackoverflow) 2015-09-04

Family

ID=47278492

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2376DEN2015 IN2015DN02376A (enrdf_load_stackoverflow) 2012-09-14 2012-11-02

Country Status (7)

Country Link
US (1) US9199977B2 (enrdf_load_stackoverflow)
EP (1) EP2895479A1 (enrdf_load_stackoverflow)
JP (1) JP5453559B1 (enrdf_load_stackoverflow)
CN (1) CN104619703A (enrdf_load_stackoverflow)
IN (1) IN2015DN02376A (enrdf_load_stackoverflow)
RU (1) RU2603963C2 (enrdf_load_stackoverflow)
WO (1) WO2014041708A1 (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5688406B2 (ja) 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011155640A1 (en) 2010-06-11 2011-12-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
JP5951864B1 (ja) * 2015-06-05 2016-07-13 株式会社ポーラファルマ 抗ジアルジア剤
JP2017101009A (ja) * 2015-12-04 2017-06-08 株式会社ポーラファルマ 抗アカントアメーバ剤及びその製造法
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3081766B2 (ja) 1994-05-06 2000-08-28 東興薬品工業株式会社 角質貯留型抗真菌外用組成物
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
GB2317615B (en) * 1995-07-08 1998-09-02 Nihon Nohyaku Co Ltd Antifungal agent compound therefor process for producing the same
JP2002114680A (ja) 2000-07-31 2002-04-16 Nippon Nohyaku Co Ltd 抗真菌剤
PL2005958T3 (pl) 2006-03-08 2013-11-29 Nihon Nohyaku Co Ltd Kompozycja farmaceutyczna do stosowania zewnętrznego
RU2415669C2 (ru) 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
CA2645058C (en) * 2006-03-08 2013-07-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
HUE030028T2 (en) 2007-09-05 2017-04-28 Pola Pharma Inc Antifungal drug
WO2009031643A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
JP5529539B2 (ja) 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
US8193232B2 (en) * 2009-02-13 2012-06-05 Topica Pharmaceuticals, Inc. Anti-fungal formulation
JP5688406B2 (ja) * 2009-04-09 2015-03-25 株式会社ポーラファルマ 抗真菌医薬組成物
WO2010117089A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2470178B1 (en) 2009-08-25 2018-10-17 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2011155640A1 (en) 2010-06-11 2011-12-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
WO2014042043A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Pharmaceutical composition containing luliconazole
WO2014042231A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Crystal and pharmaceutical preparation containing the same crystal
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
WO2014041846A1 (en) 2012-09-14 2014-03-20 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and phrmaceutical composition prepared by containing the crystal
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物

Also Published As

Publication number Publication date
US20150183766A1 (en) 2015-07-02
WO2014041708A1 (en) 2014-03-20
CN104619703A (zh) 2015-05-13
RU2603963C2 (ru) 2016-12-10
JP5453559B1 (ja) 2014-03-26
EP2895479A1 (en) 2015-07-22
RU2015109127A (ru) 2016-11-10
US9199977B2 (en) 2015-12-01
JP2014074008A (ja) 2014-04-24

Similar Documents

Publication Publication Date Title
IN2015DN02376A (enrdf_load_stackoverflow)
IN2014CN02639A (enrdf_load_stackoverflow)
MY165759A (en) Pull-on diaper
IN2015DN02929A (enrdf_load_stackoverflow)
NZ719568A (en) Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative
MX2015002487A (es) Proceso para la preparacion de teneligliptina.
IN2013MU00646A (enrdf_load_stackoverflow)
NZ708371A (en) Methods for treating pruritus
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2013DE00266A (enrdf_load_stackoverflow)
EP2990509A4 (en) METHOD FOR GROWING ß-Ga2O3-BASED SINGLE CRYSTAL
ZA201505194B (en) Plant growth regulating compounds
AU2014371081A1 (en) Polyoxalates and a Process for the Production Thereof
IN2013MU03070A (enrdf_load_stackoverflow)
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
AU2013347232A8 (en) 3-Aminocyclopentane carboxamide derivatives
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
IN2013MU04056A (enrdf_load_stackoverflow)
MX369174B (es) Proceso para la preparación de un compuesto.
IN2013CH05282A (enrdf_load_stackoverflow)
IN2013MU03755A (enrdf_load_stackoverflow)
MY168058A (en) Optical transducer with integrated feedthrough
MY185479A (en) Process for preparing heonone (meth)acrylate
MX361673B (es) Procedimiento para la preparación de intermediarios de ácido borónico.